- See the difference! Customize Seeking Alpha: Sign in or join
Seeking Alpha
Sort by:
Latest
|
Editors' Picks
|
Most Commented
|
Most Popular
-
Access Pharma: ProLindac Nicely Positioned as Improved, Safer Platinum Drug
-
Many Reasons to Launch a Global Generic Drug ETF
-
Mentor Capital Cancer Vaccine Investing Update
-
Mentor Capital Plans 2010 Launch of Cancer Vaccine Active Index Fund
-
NeoStem: Start of a New Era
-
Access Pharma: CEO Interview and Update
-
Cytori Therapeutics: Natural Celution for Breast Reconstruction
-
BioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance
-
Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife
-
BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO
-
Diabetes Care: Global Investing Opportunities
-
BioMed News Bytes: AstraZeneca, Delcath, Unilife
-
Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System
-
BioMed News Bytes: GeoVax, Cerus, Discovery Labs, NeurogesX
-
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
-
Access Pharma Looking for Smooth U.S. MuGard Launch in 2010
-
EXACT Sciences: Buy and Hold for Long-Term Upside
-
A 130 / 30 Global Pharma Strategy
-
EXACT Sciences: Patience Required for Long-Term Upside
-
Railroad Stocks Steam Ahead on Buffett’s Buy of BNI
-
Unilife: Medical Device Innovator Creating Jobs in Pennsylvania
-
BioMed News: Rockwell Medical, EXACT Sciences, MannKind
-
BioMed News Bytes: Dyax, Human Genome Sciences, Aldagen
-
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?
-
Updates on Access Pharma, BioSphere Medical, CryoLife, NeoPharm
-
ImmunoCellular's Promising Brain Cancer Vaccine
-
BioMed News: Antigenics, Shire, King Pharma, Delcath Systems
-
BioMed News Bytes: Angiotech, BioSante, HGSI
-
Celldex Therapeutics: Plenty of Cash, Pending Clinical Catalysts
-
NF Energy: Continuing Its Robust Growth
-
BioMed News Bytes: Cytori, Questcor
-
October FDA Calendar Stocks: Tricks or Treats?
Latest Comments on Mike Havrilla's Articles